INTRODUCTION
Although DNA and RNA were first discovered at the same time, it took .150 years for the RNA to emerge from the shadow of its longer sibling. Only now the full structural and regulatory role of RNA is becoming apparent, leading to the emerging understanding of the eukaryotic genome as an RNA machine (1) . Efforts of multiple scientists, fueled by the achievements of the FANTOM, and later GENCODE and ENCODE consortia, expanded the scope of RNA functions from a single role of carrying information from DNA to ribosomes to a wide spectrum of regulatory and structural roles in gene expression, genomic imprinting and chromatin rearrangement (2) (3) (4) (5) (6) . The journey of the noncoding RNA (ncRNA) from 'genomic junk' to biological prominence has arguably been long and tortuous (1, 7) .
As the identity and functions of non-coding transcripts are still in the early stages of discovery, so is their classification. A commonly used grouping based mostly on the order of discovery, divides non-coding transcripts into rRNA, tRNAs, snRNAs, snoRNAs, short (miRNA, piRNA) and long non-coding RNAs (lncRNA). However, as structures and functions of multiple noncoding transcripts become better characterized, it is becoming clear that the classification based on this grouping is not very useful. In fact, it might even impede progress by artificially separating similar entities into different classes and encouraging scientists to overlook, for example, the dual lncRNA and miRNA aspects of some ncRNAs. Even the division into coding and ncRNAs is gradually becoming less obvious, as cases are discovered where a coding gene mRNA functions as a regulatory molecule in its own right or an ncRNA is found to produce a protein (8, 9) . The current neat picture of the RNA world could be threatened even further by the recently proposed model where transcripts are generated constantly at low levels from different points of the genome to allow transcription surveillance machinery to sample the local context and engage in appropriate action.
Despite the lack of comprehensive classification, we have to limit our review to a subgroup of RNAs due to space constraints. We will focus on natural antisense transcripts (NATs) which are relatively less studied than ribosomal/tRNAs, short ncRNAs and even another subgroup of lncRNA, long-intergenic non-coding RNAs (lincRNAs) (10, 11) . Furthermore, due to their highly gene locus-specific effects, NATs may provide a unique entry point for therapeutic intervention in targeted gene upregulation (12) . For the purpose of this review, we will define NATs as ncRNAs transcribed from the opposite strand of a coding gene and capable of regulating the expression of their sense gene pair or of several related genes. As will be described, this group is highly heterogeneous. NATs may originate from all parts of a given protein coding locus. The effect of NATs on their partner coding genes could include suppression, activation or homeostatic adjustment, and the mechanisms may be as different as recruitment of epigenetic modifier enzymes, ncRNA/ mRNA pairing or stabilization of long-range chromosomal interactions. Below we will review examples of these cases.
NATS: STRUCTURAL AND FUNCTIONAL DIVERSITY

NAT sequences
For the NAT subclass as a whole, no clear sequence motifs have yet been identified. Furthermore, NAT sequences are poorly * To whom correspondence should be addressed. Tel: +1 3052431367; Fax: +1 3052432523; Email: CWahlestedt@med.miami.edu # The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com conserved among species (13) . It has been proposed that it is secondary and/or tertiary structures that are evolutionally conserved and are essential for NAT and other lncRNA functions (14) . It is also possible that closer homologies will emerge when known RNA transcripts are grouped in a different way. For example, when a group of 141 intronic regions and 74 intergenic transcripts obtained by deep sequencing of intronic and intergenic chromatin-associated RNAs was analyzed, it showed significant conservation across 44 species of mammals (15) .
Interestingly, common NAT sequences can be contributed by the transposable elements. Some of the active human endogenous retroviruses (HERVs) are transcribed from the coding gene loci in antisense direction and regulate these genes in a discordant fashion, thus qualifying as NATs (e.g. HERV-Ec1 and HERV-Ec6 proviruses located in PLA2G4A and RNGTT genes) (16) . HERV promoters frequently originate expression of new isoforms of both coding and non-coding genes (17, 18) . Some NATs contain short interspersed nuclear element B2 (SINEB2), for example antisense Uchl1 which includes a part overlapping a 5 ′ sequence of Uchl1 and an embedded inverted SINEB2 (19) . Tspo NAT was created by extension of the SINEB2 transcript to exon 3 of the Tspo gene (20) .
Some of the pseudogenes, frequently generated through inverted gene duplications, may give rise to lncRNA transcripts with regulatory functions (21) .
The search for common NAT motifs is further complicated by the fact that RNAs can combine coding and non-coding roles. For example, steroid receptor RNA activator thought to be non-coding was found to produce a highly conserved small protein (9) .
Localization of NATs relative to coding gene sequences
Known NATs overlap introns, exons, promoters, enhancers, UTRs and flanking sequences of the partner coding genes, in all combinations. Head-to-head, tail-to-tail and fully overlapped with coding gene NAT configurations have also been observed.
Several groups have attempted associating relative position of lncRNA with its function, as deduced from correlation in temporal profiles and expression levels of their partner proteincoding genes. Batagov et al. (22) found weak positive correlation in expression for coding/non-coding gene pairs at bidirectional promoters and for sense-antisense transcript pairs during a 120-h time course of differentiation of human neuroblastoma SH-SY5Y cells into neurons after treatment with retinoic acid. In contrast, lncRNAs located in the introns and downstream of the protein-coding genes showed negative correlation. Using directional RNA-seq data from of mouse and chimpanzee tissues, Uesaka et al. (23) have noted that loci with tissue-specific expression frequently contain lncRNAs overlapping the coding gene promoter (termed promoter-associated ncRNAs or pancRNAs), whereas constitutively expressed genes usually did not have pancRNAs. Furthermore, expression of pancRNAs and their coding partners was positively correlated.
Head-to-head configuration of coding/non-coding gene pairs has been closely investigated in recent years (24, 25) . It has been shown that a significant fraction of the transcription start sites of protein-coding genes may be generating bidirectional transcription (23) . More than 60% of the lncRNA transcripts in human and murine embryonic stem cells (ESCs) originate from bidirectional promoters (26) . It has been proposed that transcription of the ncRNA from these sites may be suppressed by a gene-loop configuration formed by Ssu72 protein, which interacts with both the promoter and terminator of the active protein-coding genes and restricts divergent transcription of ncRNAs (27) .
A subset of enhancers has been shown to produce lncRNAs termed eRNAs, which may form a separate NAT subgroup. Such eRNA-producing enhancer at Nanog locus exhibited decreased DNA methylation, elevated levels of the active mark H3K27Ac and DNA hydroxylase Tet1. Binding of Sall4 and Tet family proteins was necessary for eRNA transcription at this locus (28) .
Mechanisms of NAT-mediated regulation
Multiple mechanisms have been proposed for NAT-dependent regulation of coding protein expression. It is likely that the mechanism of action would constitute the most meaningful basis for NAT classification. However, the currently available data are too sketchy and only a preliminary grouping by mechanism of action type can be suggested. It is possible that as more information becomes available more NATs will be found to participate simultaneously in several types of regulation described below.
Interaction with protein complexes: decoy, scaffolding and tethering mechanisms Different authors describe lncRNAs interacting with protein complexes as decoys, scaffolds or tethers/guides. Typically, decoys interact with one partner, whereas scaffolds and tethers/guides bridge groups of targets. In practice, however, it is hard to draw a clear line between these three groups. Both tethers and scaffolds can display some aspects of decoy mechanism. The overlap is even bigger between scaffolding and tethering groups. Below, we will review some of the cases keeping the decoy, scaffold or tether/guide description given by the authors for convenience.
The decoy mechanism mostly involves different lncRNAs competing for the binding sites with other molecules (Fig. 1) . A classic case of decoy mechanism has been described by Huang et al. (29) . hnRNP I enhances the translation of p27 (Kip1) through interaction with its 5 ′ -untranslated region. lncRNA UCA1 displaces p27 RNA from the hnRNP I complex which leads to a decrease in p27 protein level. An interesting variation on the decoy mechanism is described for lncRNA cardiac hypertrophy-related factor that downregulates miR-489 expression levels by directly binding to and sequestering miR-489 in a model of AngII-induced cardiac hypertrophy (30) .
Tethering of epigenetic modulators has been first described for lncRNAs in the context of imprinting. These interactions for the most part involve polycomb group protein complexes PRC1 (polycomb repressive complex 1) and PRC2 tethering to defined gene loci. This group of interactions has recently been expanded to include developmentally and environmentally driven epigenetic modification of the non-imprinted loci (reviewed in 34, 35) (Fig. 1) . PRC2 catalyzes the di-and trimethylation of histone H3 at lysine 27 (H3K27me2 or H3K27me3), which is recognized by PRC1. PRC1 then catalyzes the monoubiquitylation of histone H2A, which contributes to chromatin compaction and repression of the target locus. The mechanism of PRC2 recruitment is currently not completely understood lncRNA may be used to tether/guide/direct the complex to particular target genes through both base pairing to DNA and secondary-tertiary structure-driven protein binding. The tethering can occur by the nascent NAT at the time of NAT transcription or after NAT transcription has been completed, by pairing with DNA or mRNA sequences. There are several possible configurations for the pairing, including base pairing between the NAT and ssDNA, formation of a RNA-DNA-DNA triplex or via RNA-RNA hybrids of NATs with a nascent partner mRNA. It is possible that tethering requires participation of other protein factors because comparing human PRC2 binding to its known target lncRNAs with PRC2 binding to irrelevant transcripts, the binding constants were found to be similar in ciliates and bacteria (36) . JARID2 could be one of the proteins that facilitates PRC2/ lncRNA interaction, at least at imprinted loci involved in differentiation, including the Dlk1-Dio3 locus (37) . Interestingly, in mouse ESCs, PRC2 is found at both active and inactive promoters, but the H3K27me3 mark is not observed at active gene loci. Using in vivo RNA-protein cross linking, it was determined that EZH2, the catalytic subunit of PRC2, directly binds the 5 ′ region of nascent coding and ncRNAs at active promoters. EZH2 binding may contribute to decreased H3K27me3 deposition at these sites through the decoy mechanism (38) . PRC2 also binds widely to enhancers, but H3K27me3 is only deposited at sites depleted for activating promoter motifs and enriched for motifs of developmental factors. These sequences represent blastula-stage DNA methylation-free domains that are conserved between humans, frogs and fish (39). The role of eRNAs in this process remains to be investigated.
Involvement of lncRNA in PRC2 recruitment, at least in the context of imprinting, has recently been questioned based on microarray-based epigenomic mapping and super-resolution 3D structured illumination microscopy data. Spatial separation and absence of colocalization of Xist and PRC2 was observed in the mouse ES cell line carrying an inducible Xist transgene located on chromosome 17 and in normal XX somatic cells (40) .
Multiple authors have reported changes in other epigenetic DNA and chromatin marks including methylation and demethylation of H3K4, H3K9, acetylation and deacetylation of histone H3 involving multiple enzymes and epigenetic complexes, such as methyltransferases G9a, GLP and HDACs (Table 1) . These alternative epigenetic modifications are likely induced by changes in NAT levels and activity.
Generation of endogenous siRNAs and miRNA/modulation of mRNA stability The first proposed mechanism of NAT-mediated gene expression regulation was based on the presence of overlapping exons between NATs and their sense gene partners as well as known information about how siRNA/miRNA acts upon messenger RNA. This evidence was used to formulate the theory that sense/antisense RNA duplex formation during or after transcription leads to either sense transcript degradation or stabilization. This mechanism overlaps with another suggested function of ncRNAs, namely serving as precursors for endogenous siRNAs and miRNA production. Although multiple examples of gene expression regulation through sense -antisense RNA interaction are known (Table 1) , it is likely that these (29, 30) . (B) Interaction with protein complexes: tethering mechanism. NAT is transcribed from the opposite strand of the protein-coding locus. The NAT-mediated tethering can occur by the nascent NAT at the time of NAT transcription or after NAT transcription has been completed, by pairing with DNA or nascent mRNA sequences. NAT then binds a protein complex (e.g. PRC2) thus tethering it to the coding gene locus, and/or scaffolding several proteins at the promoter site. PRC2 catalyzes the trimethylation of histone H3 at lysine 27 (H3K27me3), which is recognized by PRC1. PRC1 then catalyzes the monoubiquitylation of histone H2A, which contributes to chromatin compaction and repression of the target locus (2, 31) . (C) Generation of endogenous siRNAs and miRNA. NAT forms internal hairpins or duplexes with mRNA in the areas of homology. The doublestranded RNA stretches are trimmed by Dicer to form short RNA duplexes, which are then bound by the RISC complex and used as a template for recognition of mRNA. Captured mRNA is then cleaved by the RISC complex, reducing protein expression (32, 33) .
R56
Human Overexpression (25) mechanisms are not very widespread, because only 1% of the genome is transcribed from both plus and minus strands (23) . The biological importance of the sense -antisense RNA interaction is supported by recent findings showing that a subset of lncRNA is enriched in the cytosol and in ribosomal fractions rather than in the nucleus (69) . In mouse CD4+ T cells multiple endogenous siRNA and miRNA transcripts were identified. These transcripts interacted with argonaute (AGO) proteins that mediated RNA interference and posttranscriptional gene silencing (32) . Short RNA-seq and cross linking, ligation and sequencing of hybrids of human embryonic kidney cell (HEK293) RNA yielded antisense transcripts from 378 genes with a characteristic endo-siRNA footprint (co-occurrence of RNAPII and AGO1); (33) .
lncRNA in stabilization of long-range chromosomal interactions Advanced methods, including chromatin conformation capture and its modifications, 4C, 5C and Hi-C (1 -3), have revealed long-range chromosomal interactions in B-and T-cell receptor loci (reviewed in 70). Multiple chromatin loops in these loci may form rosette-like structures that bring distant chromosomal regions into the same transcription factory. These structures may be formed with participation of CTCF and cohesin proteins and lncRNAs.
THERAPEUTIC APPLICATIONS OF NATS
The high target specificity of NATs that normally regulate one gene or a small group of related genes makes them a welcome addition to the list of targets available for therapeutic intervention. A growing number of NATs in disease-relevant loci is being characterized (Tables 1 and 2 ). Although functional NATs were described as early as mid-1990, the therapeutic application for them was not proposed until mid-2000s (81) . Whereas some authors suggest using NATs and other lncRNAs for gene downregulation (55) , a more unique therapeutic aspect of NATs is their ability to increase the expression of specific genes (12,82 -85) . This approach is currently being brought into practice by at least two biotechnology companies utilizing related NAT-targeting technologies: (i) oligonucleotides interfering with NAT function through steric hindrance or RNAse H-mediated degradation (OPKO CURNA, Miramar, FL, USA; founded 2008) and (ii) oligonucleotides targeting NAT interaction with PRC2 (RaNA, Cambridge, MA, USA; founded 2011). Additionally, manipulation of regulatory pseudogene transcripts through the use of synthetic antisense oligonucleotides, siRNAs, aptamers or gene therapy has been proposed as a novel pharmacological strategy (21) . An algorithm to design short ncRNAs for the epigenetic transcriptional silencing or activation of specific genes has been published (86) .
The two main areas for which ncRNA-based therapies are now being developed are cancers and rare genetic disorders. Cancer applications are mostly based on lincRNAs (reviewed in 87 -89) . Examples of ncRNAs likely associated with rare genetic disorders are given in Table 2 and have been recently reviewed (90). 
